Rubius Therapeutics Inc (Over The Counter Market:RUBY)
| 0.019 Delayed Data As of 12:00am ET |  +0.0007 / +3.83%Today’s Change | 0.00 Today|||52-Week Range 0.42 | -89.14% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | -- | -- |
| Depreciation And Amortization | 118.0K | 447.0K | 1.3M | -- | ||
| Operating Expenses | Gross Income | -118.0K | -447.0K | -1.3M | -- | |
| General Expenses | 10.7M | 42.8M | 90.4M | -- | ||
| Research And Development | 8.4M | 21.2M | 51.8M | -- | ||
| Total Operating Expenses | 10.9M | 43.3M | 91.7M | -- | ||
| Non-Operating Expenses | Operating Income | -10.9M | -43.3M | -91.7M | -- | |
| Extraordinary Credit | 1.0K | 0.00 | 0.00 | -- | ||
| Extraordinary Charge | -- | -785.0K | -2.2M | -- | ||
| Interest Expense On Debt | 149.0K | 309.0K | 464.0K | -- | ||
| Other Expenses | -16.0K | 511.0K | 5.1M | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -11.0M | -43.8M | -89.2M | -- | |
| Preferred Dividend | -748.0K | -656.0K | 0.00 | -- | ||
| Net Income | -11.0M | -43.8M | -89.2M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 78.9M | 78.9M | 39.3M | -- | |
| Shares To Calculate EPS Diluted | 78.9M | 78.9M | 39.3M | -- | ||
| Earnings Per Share | EPS | -$0.15 | -$0.56 | -$2.27 | -- | |
| EPS Diluted | -$0.15 | -$0.56 | -$2.27 | -- | ||
